This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Van Andel Research Institute. Active years: 2025.
Company Filing History:


Years Active: 2025
Title: **Innovations and Contributions of Inventor Erli You**
Introduction
Erli You, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals. With a focus on developing novel compounds, he has successfully patented an innovative small molecule agonist aimed at treating FXR-related diseases.
Latest Patents
Erli You holds one noteworthy patent titled "FXR small molecule agonist and preparation method therefor and use thereof." This patent describes a compound with FXR agonistic activity, demonstrating the potential for therapeutic applications in managing conditions associated with FXR dysregulation. The innovative structure of this compound is detailed in formula (I) within the patent documentation.
Career Highlights
Throughout his career, Erli You has built a robust reputation in the scientific community. He has worked at prestigious research institutions, including the Chinese Academy of Sciences and the Van Andel Research Institute. His experience in these prominent organizations has enabled him to deepen his expertise and foster a research-oriented approach to drug development.
Collaborations
Erli You has collaborated with notable colleagues, including Huaqiang Xu and Jia Tao Li. These partnerships have been instrumental in advancing his research and contributing to the development of innovative pharmaceutical solutions. Their collective efforts reflect a commitment to addressing significant health challenges through scientific inquiry.
Conclusion
In summary, inventor Erli You stands out in the realm of pharmaceutical innovation with his patented FXR small molecule agonist. His collaborative work and experience at leading research institutions highlight his dedication to advancing medical science. With ongoing research and potential for further patents, Erli You's contributions continue to shape the future of disease treatment and drug discovery.